B Raf (BRAF) (NM_004333) Mutant (V600E) Human Recombinant Protein

CAT:
882-PH33000M5
Size:
20 µg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
B Raf (BRAF) (NM_004333) Mutant (V600E) Human Recombinant Protein - image 1

B Raf (BRAF) (NM_004333) Mutant (V600E) Human Recombinant Protein

  • Background:

    This gene encodes a protein belonging to the RAF family of serine/threonine protein kinases. This protein plays a role in regulating the MAP kinase/ERK signaling pathway, which affects cell division, differentiation, and secretion. Mutations in this gene, most commonly the V600E mutation, are the most frequently identified cancer-causing mutations in melanoma, and have been identified in various other cancers as well, including non-Hodgkin lymphoma, colorectal cancer, thyroid carcinoma, non-small cell lung carcinoma, hairy cell leukemia and adenocarcinoma of lung. Mutations in this gene are also associated with cardiofaciocutaneous, Noonan, and Costello syndromes, which exhibit overlapping phenotypes. A pseudogene of this gene has been identified on the X chromosome. [provided by RefSeq, Aug 2017]
  • Synonyms:

    B-raf; B-RAF1; BRAF1; NS7; RAFB1
  • Gene ID:

    673
  • UniProt:

    P15056
  • Accession Number mRNA:

    NM_004333
  • Chromosomal Location:

    7q34
  • Expression System:

    HEK293
  • Tag:

    C-Myc/DDK
  • Related Pathways:

    Acute myeloid leukemia, Bladder cancer, Chemokine signaling pathway, Chronic myeloid leukemia, Colorectal cancer, Endometrial cancer, ErbB signaling pathway, Focal adhesion, Glioma, Insulin signaling pathway, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanoma, mTOR signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Non-small cell lung cancer, Pancreatic cancer, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Regulation of actin cytoskeleton, Renal cell carcinoma, Thyroid cancer, Vascular smooth muscle contraction
  • Field of Research:

    Acute myeloid leukemia, Bladder cancer, Chemokine signaling pathway, Chronic myeloid leukemia, Colorectal cancer, Endometrial cancer, ErbB signaling pathway, Focal adhesion, Glioma, Insulin signaling pathway, Long-term depression, Long-term potentiation, MAPK signaling pathway, Melanoma, mTOR signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Non-small cell lung cancer, Pancreatic cancer, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Regulation of actin cytoskeleton, Renal cell carcinoma, Thyroid cancer, Vascular smooth muscle contraction
  • Concentration:

    >50 ug/mL as determined by microplate BCA method
  • Purity:

    > 80% as determined by SDS-PAGE and Coomassie blue staining
  • Activity:

    26814611
  • Form:

    Liquid
  • Buffer:

    25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10% glycerol
  • Function:

    Druggable Genome, Protein Kinase
  • Molecular Weight:

    84 kDa
  • Storage Conditions:

    Stable for 1 year at -20°C or below from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and opening the cap. For long-term storage, aliquot and store at -20°C or below. Avoid repeated freeze-thaw cycles.
  • Symbol:

    BRAF
  • Species:

    Human
  • Protein ID:

    NP_004324
  • Overview:

    Recombinant protein of human v-raf murine sarcoma viral oncogene homolog B1 (BRAF) V600E mutant, expressed in human cells
  • Gene ID URL:

    https://www.ncbi.nlm.nih.gov/gene/673
  • Uniprot URL:

    https://www.uniprot.org/uniprot/P15056
  • Accession Number mRNA URL:

    https://www.ncbi.nlm.nih.gov/nuccore/NM_004333
  • Protein ID Link:

    https://www.ncbi.nlm.nih.gov/nuccore/NP_004324